| Conferences \ Advances in Drug Discovery \ Stem Cells in Drug Discovery \ Agenda \ Glyn Stacey |
| Register | Login |
QC and Assay Development for Product Safety Testing Using Pluripotent Stem Cell Based SystemsMonday, 6 March 2017 at 10:15  Add to Calendar ▼2017-03-06 10:15:002017-03-06 11:15:00Europe/LondonQC and Assay Development for Product Safety Testing Using Pluripotent Stem Cell Based SystemsSELECTBIOenquiries@selectbiosciences.comThe development of assays for product safety testing based on human pluripotent stem cell lines requires careful evaluation of the starting cell line and qualification of the protocol to deliver the final cells for testing. In the is presentation will consider experiences in addressing these issues in the Seurat-1 EC/Colipa funded programme and new initiatives in the development of best practice for stem cell culture and assay development. |
Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonStem Cells in Drug DiscoverySELECTBIOenquiries@selectbiosciences.com
.gif){kind=logo}
